Charles S. Fuchs, MD, MPH
Charles S. Fuchs, MD, MPH, was appointed the Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. Prior to joining Yale, Dr. Fuchs was the Director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, Professor of Medicine at Harvard Medical School and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer. He led the Dana-Farber/Harvard Cancer Center Gastrointestinal Malignancies Program and the DF/HCC SPORE Grant in Gastrointestinal Cancers.
In addition to his leadership responsibilities, Dr. Fuchs splits his time between laboratory-based research, clinical research, and clinical patient care. His laboratory focuses on biochemical markers of GI cancer risk, molecular predictors of patient prognosis in colorectal and pancreatic cancers, and the discovery of novel targets for therapy. Dr. Fuchs is a member of the Scientific Advisory Board for the Lustgarten Foundation for Pancreatic Cancer and a cadre member of GI Committee for Cancer and Leukemia Group B.
Dr. Fuchs has published over 500 scientific publications in such journals as The New England Journal of Medicine, Lancet, Journal of the American Medical Association, Journal of Clinical Oncology, Cell, and Nature. He is a graduate of Harvard Medical School and completed his residency training at Brigham and Women’s Hospital. He completed a medical oncology fellowship at Dana-Farber.